Abstract

Introduction

According to immunological theories of schizophrenia prenatal and postnatal exposure to pathogens may contribute to the etiopathogenesis, suggesting that chronically activated immune system cells (macrophages and T lymphocytes) constantly secrete proinflammatory cytokines which affect the development and function of central nervous system.

Objectives

In the present work we aimed to evaluate IL-1β plasma levels in schizophrenic patients during their first psychotic episode and to compare the obtained results to those from healthy subjects.

Methods

Plasma was obtained from 32 drug-naive schizophrenic patients, without history of substance abuse or addiction, immediately after their admission to the medical ward, while the control samples were obtained from 20 healthy volunteers.

Results

Levels of IL-1β were measured using ELISA assay, which measures IL-1β protein in a range from 7.81 to 500 pg/ml. Results revealed that the levels of IL-1β in patients with first psychotic episode were not increased and were below the limit of detection in all studied samples. The same was found in the samples belonging to the control group.

Conclusions

These data contribute to the poll of knowledge and a still unresolved dogma about the etiopathogenesis of schizophrenia since the results obtained by some studies are also questioning this marker. Thus, whether or not an increase of IL-1β is congenital, acquired during the prodromal phase or absent until the time of first psychotic episode has not yet been investigated.

Disclosure of Interest

None Declared

Details

Title
Relation between the first psychotic episode in schizophrenia patients and IL-1β plasma levels – Serbian population study
Author
Stojanovic, N M 1 ; Golubović, S Tošić 2 ; Vujić, S 3 ; Stefanović, N 3 ; Nikolić, G 4 ; Todorović, A 5 ; Vrućinić, A 6 ; Petković, M 1 ; Simonović, M 4 ; Randjelovic, P 1 ; Stoimenov, T Jevtović 7 

 Department of Physiology 
 Department of Psychiatry, Faculty of Medicine, University of Niš; Clinic for Psychiatry, University Clinical Centre 
 Faculty of Medicine, University of Niš 
 Department of Psychiatry, Faculty of Medicine, University of Niš; Centre for mental health, University Clinical Centre 
 Special Psychiatric Hospital 
 Department of Psychiatry, University Clinical Centre 
 Department of Biochemistry, Faculty of Medicine, University of Niš, Niš, Serbia 
Pages
S388-S388
Publication year
2024
Publication date
Aug 2024
Publisher
Cambridge University Press
ISSN
09249338
e-ISSN
17783585
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3097364230
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association. This work is licensed under the Creative Commons Attribution License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.